Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Endocrinology Drugs Market by, Therapy Area
6.1 Overview
6.2 Adrenal Insufficiency
6.3 Diabetes
6.4 Growth Hormone Disorders
6.5 Pituitary Gland Disorders
6.6 Polycystic Ovary Syndrome (PCOS)
6.7 Thyroid Hormone Disorder
6.8 Other Therapy Areas


7 Global Endocrinology Drugs Market by, Drug Class
7.1 Overview
7.2 Antidiabetic Drugs
7.3 Thyroid Drugs
7.4 Steroid Hormones
7.5 Hypothalamic and Pituitary Hormones


8 Global Endocrinology Drugs Market by, Distribution Channel
8.1 Overview
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
8.4 Online Pharmacies


9 Global Endocrinology Drugs Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa


10 Key Developments


11 Company Profiling
11.1 Abbott Laboratories
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 AbbVie Inc
11.3 AstraZeneca PLC
11.4 Bayer AG
11.5 Biocon
11.6 Eli Lilly and Company
11.7 Merck KGaA
11.8 Novartis AG
11.9 Novo Nordisk A/S
11.10 Pfizer Inc
11.11 Sanofi
11.12 Takeda Pharmaceutical Company Limited